ArticleVirulence2026
The CCR2 inflammatory pathway is a target for improving severe disease and pulmonary inflammation in experimental COVID-19.
Yvette Kazungu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it